首页 正文

Eligibility and Endpoints for Clinical Trials in Trimodality Therapy for Bladder Cancer

{{output}}
Background: Trimodality therapy (TMT) is a viable option for muscle-invasive localized bladder cancer, providing an alternative to radical cystectomy in properly selected patients. The approval of novel therapeutics in different ... ...